Results
1
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
1 companies
argenx
Market Cap: €29.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€483.10
7D
-5.9%
1Y
35.9%